Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets end flat
Mon, 21 Sep Closing

After opening weak in the morning session, the Indian markets pared losses in the post noon trading session and finished the day just below the dotted line. While BSE Sensex was down by 26 points, the NSE-Nifty too closed down by 5 points. While most of the sectoral indices ended in green, the mid and small cap indices too gathered steam. The BSE Mid Cap and the BSE Small Cap indices were up by 0.4% and 1.2% respectively. FMCG and oil & gas stocks witnessed maximum selling pressure.

Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 1.89%, while the Nikkei 225 led the Hang Seng lower. They fell 1.96% and 0.80% respectively. European markets are mixed today. The CAC 40 is up 1.12%, while the FTSE 100 gains 0.53%. The DAX is off 0.50%. The rupee gave up early losses, but was still trading down by 10 paise at 65.77 against the US$ in the afternoon session.

According to a leading financial daily, Strides Arcolab and Sun Pharmaceutical Industries have entered into a definitive agreement related to erstwhile Ranbaxy's 'Solus' and 'Solus Care' divisions operating in the central nervous system (CNS) segment in India. The agreement involves transfer of these two marketing divisions, along with employees to Strides for a consideration of Rs 1.65 bn. As per IMS July 2015 MAT report, all the products of these two divisions together accounted for approximately Rs 920 m in sales. Strides Arcolab ended the trading day up by 4.8% on the BSE.

Engineering sector ended the trading day with modest gains with Voltamp Transformers and Manugraph India leading the pack of gainers. According to a leading financial daily, Bharat Heavy Electricals (BHEL) has commenced first unit of the upcoming 3x660 MW Supercritical Thermal Power Plant at Mirchwara in Lalitpur district of Bundelkhand in Uttar Pradesh. The unit has been synchronized by the company three months ahead of the schedule agreed between Lalitpur Super Thermal Power Project and BHEL. The commencement of the unit by the company will result in improvement of power availability in the state of Uttar Pradesh. The second and third units of the project are also in advanced stages of completion. Further, in Uttar Pradesh, three supercritical thermal units at Bara (3x660 MW) and the second 500 MW unit at Anpara, being set up by BHEL, are also in advanced stages of completion.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets end flat". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.